Unity Biotechnology, Inc.
UBXDelisted Aug 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001463361
Unity Biotechnology, Inc. was delisted on Aug 6, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Unity Biotechnology, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −1 vs. Q1 2024
- Shares held
- 3.45M
- −131.8K (−3.7%) vs. Q1 2024
- Total value
- $4.66M
- −$1.22M (−20.7%) vs. Q1 2024
- New holders
- 6
- 7 more added
- Sold out
- 7
- 11 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting UBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 6 | $1.68K |
| Q2 2025 | 35 | $987.3K |
| Q1 2025 | 40 | $2.95M |
| Q4 2024 | 37 | $3.10M |
| Q3 2024 | 38 | $5.09M |
| Q2 2024 | 39 | $4.66M |
| Q1 2024 | 40 | $5.87M |
| Q4 2023 | 42 | $8.33M |
| Q3 2023 | 36 | $6.42M |
| Q2 2023 | 40 | $6.87M |
| Q1 2023 | 46 | $5.13M |
| Q4 2022 | 54 | $12.6M |
| Q3 2022 | 72 | $24.1M |
| Q2 2022 | 66 | $5.31M |
| Q1 2022 | 71 | $14.2M |
| Q4 2021 | 72 | $21.3M |
| Q3 2021 | 84 | $42.1M |
| Q2 2021 | 98 | $84.0M |
| Q1 2021 | 92 | $121.8M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Unity Biotechnology, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 391 | $0 | 0.00% | +250+177.3% | Added |
| Qube Research & Technologies Ltd | 18 | $25 | 0.00% | 00.0% | Unchanged |
| Redwood Wealth Management Group, LLC | 20 | $27 | 0.00% | +20 | New |
| Farther Finance Advisors, LLC | 20 | $27 | 0.00% | +20 | New |
| HHM Wealth Advisors, LLC | 25 | $34 | 0.00% | +25 | New |
| AllSquare Wealth Management LLC | 55 | $74 | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 100 | $135 | 0.00% | 00.0% | Unchanged |
| Carmichael Hill & Associates, Inc. | 100 | $135 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 125 | $169 | 0.00% | +125 | New |
| Rhumbline Advisers | 129 | $174 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 200 | $270 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 200 | $270 | 0.00% | +200 | New |
| Simplex Trading, LLC | 1,187 | $1.00K | 0.00% | −427−26.5% | Reduced |
| CWM, LLC | 500 | $1.00K | 0.00% | +500 | New |
| JPMorgan Chase & Co | 783 | $1.06K | 0.00% | +512+188.9% | Added |
| Glen Eagle Advisors, LLC | 1,104 | $1.49K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 3,500 | $4.72K | 0.00% | −2,843−44.8% | Reduced |
| Tower Research Capital LLC (TRC) | 4,799 | $6.48K | 0.00% | −113−2.3% | Reduced |
| Millennium Management LLC | 10,479 | $14.1K | 0.00% | −27,233−72.2% | Reduced |
| Advisor Group Holdings, Inc. | 13,063 | $17.6K | 0.00% | −22−0.2% | Reduced |
| Endowment Wealth Management, Inc. | 13,495 | $18.2K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 17,837 | $24.1K | 0.00% | +1,397+8.5% | Added |
| Northern Trust Corp | 22,549 | $30.4K | 0.00% | −30−0.1% | Reduced |
| Commonwealth Equity Services, LLC | 24,612 | $33.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 25,000 | $33.8K | 0.00% | −25,000−50.0% | Reduced |
| State Street Corp | 37,824 | $51.1K | 0.00% | 00.0% | Unchanged |
| Cercano Management LLC | 41,238 | $55.7K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 43,402 | $58.6K | 0.00% | −119−0.3% | Reduced |
| Founders Fund V Management, LLC | 49,172 | $66.4K | 7.85% | 00.0% | Unchanged |
| Morgan Stanley | 53,208 | $71.8K | 0.00% | +15,798+42.2% | Added |
| Renaissance Technologies LLC | 64,582 | $87.2K | 0.00% | −42,359−39.6% | Reduced |
| UBS Oconnor LLC | 71,983 | $97.2K | 0.00% | +1,586+2.3% | Added |
| Citadel Advisors LLC | 72,208 | $97.5K | 0.00% | −21,383−22.8% | Reduced |
| BlackRock Inc. | 88,385 | $119.3K | 0.00% | −23,944−21.3% | Reduced |
| Mayo Clinic | 124,081 | $167.5K | 5.53% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 149,043 | $201.3K | 0.00% | +14,910+11.1% | Added |
| Vanguard Group Inc | 590,770 | $797.5K | 0.00% | +33,417+6.0% | Added |
| Alyeska Investment Group, L.P. | 920,013 | $1.24M | 0.01% | 00.0% | Unchanged |
| ARCH Venture Management, LLC | 1,004,817 | $1.36M | 0.51% | 00.0% | Unchanged |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −17,865−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −13,938−100.0% | Sold out |
| CIBC Asset Management Inc | 0 | $0 | 0.00% | −10,634−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −10,455−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,494−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −678−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |